Low density lipoprotein landmark trials: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) Created page with "__NOTOC__ {{LDL}} {{CMG}} ==Overview== ==Landmark Trials== * Heart Protection Study * ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial * P..." |
Rim Halaby (talk | contribs) |
||
Line 6: | Line 6: | ||
==Landmark Trials== | ==Landmark Trials== | ||
* WOSCOPS | |||
* AFCAPS/TexCAPS | |||
* MEGA | |||
* ASCOT-LLA: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm | |||
* Jupiter | |||
* Heart Protection Study | * Heart Protection Study | ||
* ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial | * ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial | ||
* PROVE IT: Pravastatin or Atorvastatin Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction | * PROVE IT: Pravastatin or Atorvastatin Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction | ||
* PROSPER: Prospective Study of Pravastatin in the Elderly at Risk | * PROSPER: Prospective Study of Pravastatin in the Elderly at Risk | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 13:28, 28 September 2014
Low Density Lipoprotein Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Low density lipoprotein landmark trials On the Web |
American Roentgen Ray Society Images of Low density lipoprotein landmark trials |
Risk calculators and risk factors for Low density lipoprotein landmark trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Landmark Trials
- WOSCOPS
- AFCAPS/TexCAPS
- MEGA
- ASCOT-LLA: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm
- Jupiter
- Heart Protection Study
- ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial
- PROVE IT: Pravastatin or Atorvastatin Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction
- PROSPER: Prospective Study of Pravastatin in the Elderly at Risk